Secondary efficacy measures included changes from baseline in: fast plasma glucose (FPG), postprandial plasma glucose (PPG), area under the curve, insulin, C-peptide, glucagon, insulin/proinsulin ratio, body measurements, and fasting lipid profiles
Appetite increases
pylori eradication therapy, Zollinger-Ellison syndrome, and other hypersecretory states
Chinas GLP-1 market is similarly expected to grow substantially, with analysts estimating it could reach RMB 100 billion (US$14 billion) by 2030
Beyond these practical advantages, the technology is also valued for its capacity to markedly enhance the shelf stability and functional preservation of sensitive ingredients, properties that have contributed to its extensive adoption in the pharmaceutical sector